Sigma Healthcare Limited (ASX:SIG)
Australia · Delayed Price · Currency is AUD | Market Cap | 31.75B -12.7% |
| Revenue (ttm) | 9.55B +208.9% |
| Net Income | 599.81M +97.1% |
| EPS | 0.05 -72.9% |
| Shares Out | 11.50B |
| PE Ratio | 51.91 |
| Forward PE | 39.15 |
| Dividend | 0.01 (0.46%) |
| Ex-Dividend Date | Mar 4, 2026 |
| Volume | 24,448,423 |
| Open | 2.800 |
| Previous Close | 2.810 |
| Day's Range | 2.760 - 2.800 |
| 52-Week Range | 2.580 - 3.270 |
| Beta | 0.34 |
| Analysts | Buy |
| Price Target | 3.33 (+20.65%) |
| Earnings Date | Aug 21, 2026 |
About Sigma Healthcare
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies primarily in Australia. It offers support services to a network of franchised retail pharmacies; third and fourth party logistics services to pharmaceutical manufacturers and other supplier partners; and health services. The company operates stores under the Chemist Warehouse, Amcal, and Discount Drug stores brand names. It also offers products through online. The company was founded in 1912 and is headquartered... [Read more]
Financial Performance
In fiscal year 2025, Sigma Healthcare's revenue was 6.00 billion, an increase of 82.18% compared to the previous year's 3.29 billion. Earnings were 529.91 million, a decrease of -2.05%.
Financial StatementsAnalyst Summary
According to 15 analysts, the average rating for SIG stock is "Buy." The 12-month stock price target is $3.33, which is an increase of 20.65% from the latest price.
News
Sigma Healthcare pulls out of Boots takeover talks
The UK beauty and pharmacy giant revealed last week that it had held early discussions over a potential takeover deal.
Australia’s Sigma drops out of talks to buy UK’s Boots
End of discussions on takeover estimated at $10bn extends uncertainty for 177-year-old British chain Business live – latest updates The Australian pharmaceutical group Sigma Healthcare has dropped its...
Sigma Healthcare stock jumps 8% after pulling out of billion-dollar Boots deal
Sigma Healthcare stock jumped on Monday after the Australian pharmacy group walked away from a potential deal to buy UK pharmacy chain Boots. The development looks like a rare case of investors reward...
Sigma Healthcare Withdraws From Boots Group Sale Process; Stock Up
(RTTNews) - Sigma Healthcare Limited (SIG.AX) announced that, following preliminary discussions regarding the sale process of The Boots Group, its Board has elected to withdraw interest and cease disc...
Australia's Sigma Healthcare drops pursuit of UK pharmacy chain Boots
Australia's Sigma Healthcare said on Monday it had walked away from preliminary talks to buy British pharmacy chain Boots, concluding that a potential deal would not meet its strategic and capital...
Sigma Healthcare (SIG) Faces 5.5% Drop Amid Acquisition Talks
Sigma Healthcare (SIG) Faces 5.5% Drop Amid Acquisition Talks
Sigma Healthcare (SIG) Initiates Talks to Acquire Boots Pharmacy
Sigma Healthcare (SIG) Initiates Talks to Acquire Boots Pharmacy
Sigma Healthcare in preliminary discussions to buy Boots
The company said, “Sigma Healthcare (SIGGF) refers to the recent media speculation regarding the sale process of The Boots Group. Sigma continuously reviews opportunities that would create value for s...
Sigma Healthcare in Preliminary Talks to Buy U.K.'s Boots
Australia's Sigma Healthcare said it is involved in early discussions about a potential acquisition of U.K. drugstore chain Boots.
G+T, HSFK, Freshfields on the tools for Chemist Warehouse’s Boots bid
It would see Sigma Healthcare lock horns with Canada’s wealthy Weston family, which owns the grocery chain Loblaws and pharmacy chain Shoppers Drug Mart.
Boots set to snub stock market return as it eyes £7.5bn sale: High Street giant in talks with suitors in blow to City
Boots' owner Sycamore Partners is in discussions with potential buyers including the family behind Primark as well as Australian pharmacists Sigma Healthcare.
Sigma Healthcare initiated with a Sector Perform at RBC Capital
RBC Capital analyst Michael Toner initiated coverage of Sigma Healthcare (SIGGF) with a Sector Perform rating and A$2.50 price target The firm cites risks from the company’s early international expans...
Sigma Healthcare Earnings Call Transcript: H1 2026
Revenue grew 15% year-over-year, with strong domestic and international sales, and normalized EBIT up 18.7%. Integration synergies and disciplined cost control supported margin expansion, while GLP-1 medicines drove significant sales growth.
Sigma Healthcare Quarterly report: H1 2026
Sigma Healthcare has published its H1 2026 quarterly earnings report on February 25, 2026.
Sigma Healthcare Slides: H1 2026
Sigma Healthcare has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 25, 2026.
Sigma Healthcare Earnings release: H1 2026
Sigma Healthcare released its H1 2026 earnings on February 25, 2026, summarizing the period's financial results.
Sigma Healthcare initiated with a Buy at Goldman Sachs
Goldman Sachs initiated coverage of Sigma Healthcare (SIGGF) with a Buy rating and A$3.50 price target The firm sees upside the company’s margin estimates and the stock’s valuation. Published first…
Sigma Healthcare Transcript: AGM 2025
The AGM highlighted strong financial growth post-merger, upgraded synergy targets, and robust governance enhancements. Shareholders approved all resolutions, including director reelections and remuneration reports, while the board addressed integration, remuneration, and related party governance in detail.
Sigma Healthcare Slides: FY 2025
Sigma Healthcare has posted slides in relation to its FY 2025 quarterly earnings report, which was published on October 21, 2025.
Sigma Healthcare Earnings Call Transcript: H2 2025
Strong post-merger results with revenue up 82% and normalized EBIT up 41%. Store network expansion, own brand growth, and upgraded synergy targets drive performance, while integration and competitive pressures remain key focus areas.
Sigma Healthcare Annual report: H2 2025
Sigma Healthcare has published its H2 2025 annual report on September 8, 2025.
Sigma Healthcare Slides: H2 2025
Sigma Healthcare has posted slides in relation to its H2 2025 quarterly earnings report, which was published on September 8, 2025.
Sigma Healthcare Earnings release: H2 2025
Sigma Healthcare released its H2 2025 earnings on September 8, 2025, summarizing the period's financial results.
Sigma Healthcare Slides: Company Presentation
Sigma Healthcare has posted slides in relation to its latest quarterly earnings report, which was published on May 5, 2025.
Sigma Healthcare Press release: Trading Update
Sigma Healthcare issued a press release on May 5, 2025, disclosing material business information to investors.